Ziemssen, T., Bass, A. D., Wijmeersch, B. V., Eichau, S., Richter, S., Hoffmann, F., . . . Singer, B. A. Long-term efficacy and safety of alemtuzumab in participants with highly active MS: TOPAZ clinical trial and interim analysis of TREAT-MS real-world study. SAGE Publishing.
Chicago Style (17th ed.) CitationZiemssen, Tjalf, et al. Long-term Efficacy and Safety of Alemtuzumab in Participants with Highly Active MS: TOPAZ Clinical Trial and Interim Analysis of TREAT-MS Real-world Study. SAGE Publishing.
MLA (9th ed.) CitationZiemssen, Tjalf, et al. Long-term Efficacy and Safety of Alemtuzumab in Participants with Highly Active MS: TOPAZ Clinical Trial and Interim Analysis of TREAT-MS Real-world Study. SAGE Publishing.
Warning: These citations may not always be 100% accurate.